{
    "16E.F": {
        "short_name": "EPISURF MEDICAL AB B",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, and the United Kingdom. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for treating elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, the company offers \u00c2\u00b5iFidelity system for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was founded in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "49Z.F": {
        "short_name": "CELLINK AB AK B  O.N.",
        "long_name": "Cellink AB (publ)",
        "summary": "Cellink AB (publ) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide. It offers bioprinters, imaging systems, dispensing solutions, and bioinks in the field of academic and clinical medicine for labs and scientists worldwide. The company's bioprinting solutions include BIO X, a bioprinter for life-science companies, researchers, and innovators; BIO X6, a bioprinting platform for printing complex structures; INKREDIBLE and INKREDIBLE+, which are bioprinting solutions for skin, cartilage tissue, and others; Holograph X, a solution that leverages high-resolution holographic stereolithography to bioprint small structures; Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures, and others; and tool heads and print heads. It also offers biofluidics solutions, which include I-DOT, a solution for liquid-handling tasks; single-cell printer, an automated laboratory instrument; c.sight, a single-cell dispensing technology for cell line development and single-cell genomics; b.sight, a solution that enables prokaryotic cell isolation in the sub-micron range; and f.sight, a solution that dispenses unlabeled and fluorescent cells. The company offers bioinks for various applications, such as drug screening, tissue models, tissue regeneration, organoids, immunotherapy, microfluidics, scaffolds, encapsulation, wound healing, cosmetics, educational models, and others; CELLCYTE X, a live cell microscopy imaging system; and accessories, such as consumables, needles, and nozzles. Its customers also include universities, hospitals, and public and commercial laboratories. Cellink AB (publ) has a collaboration with MedImmune; and strategic partnership with Made In Space, Inc. It also offers products online. The company was founded in 2016 and is based in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "4Z7.F": {
        "short_name": "IRRAS AB",
        "long_name": "IRRAS AB (publ)",
        "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to improve the lives of critically ill patients worldwide. The company designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. It offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. The company also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include SynergyDuo Ventricular Catheter (H610), and Parenchymal Catheter (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "5J3.F": {
        "short_name": "SCIBASE HOLDING AB",
        "long_name": "SciBase Holding AB (publ)",
        "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "5J6.F": {
        "short_name": "OSSDSIGN AB",
        "long_name": "OssDsign AB (publ)",
        "summary": "OssDsign AB (publ), a medtech company, designs, manufactures, and markets implants for healing of bone defects in Sweden and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage. The company was founded in 2011 and is headquartered in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "5JE.F": {
        "short_name": "BACTIGUARD HLDG B",
        "long_name": "Bactiguard Holding AB (publ)",
        "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions primarily in Sweden and Malaysia. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the blood stream, and the respiratory tract areas. Its product portfolio consists of indwelling Foley catheters that are used for drainage and irrigation of the bladder or for the collection and measurement of patient urine; endotracheal tubes for use in airway management by oral or nasal intubation of the trachea; and central venous catheters, which is used to administer drugs and intravenous solutions, sample blood, and for blood pressure monitoring. The company markets its products through distributors in 40 countries. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Tullinge"
    },
    "61LA.F": {
        "short_name": "SECTRA AB B(P.S.)SK 0,125",
        "long_name": "Sectra AB (publ)",
        "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Link\u00c3\u00b6ping"
    },
    "7AC.F": {
        "short_name": "ACARIX AB",
        "long_name": "Acarix AB (publ)",
        "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in Malm\u00c3\u00b6, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Malm\u00c3\u00b6"
    },
    "ACARIX.ST": {
        "short_name": "Acarix AB",
        "long_name": "Acarix AB (publ)",
        "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in Malm\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Malm\u00c3\u00b6"
    },
    "ADDV-A.ST": {
        "short_name": "ADDvise Group AB A",
        "long_name": "ADDvise Group AB (publ)",
        "summary": "ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit provides medical devices and consumable materials, including defibrillators and chairs for use in the urology and gynecology areas, as well as surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "ADDV-B.ST": {
        "short_name": "ADDvise Group AB B",
        "long_name": "ADDvise Group AB (publ)",
        "summary": "ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit provides medical devices and consumable materials, including defibrillators and chairs for use in the urology and gynecology areas, as well as surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "ARCOMA.ST": {
        "short_name": "Arcoma AB",
        "long_name": "Arcoma AB",
        "summary": "Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in V\u00c3\u00a4xj\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "V\u00c3\u00a4xj\u00c3\u00b6"
    },
    "BACTI-B.ST": {
        "short_name": "Bactiguard Holding AB ser. B",
        "long_name": "Bactiguard Holding AB (publ)",
        "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions primarily in Sweden and Malaysia. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the blood stream, and the respiratory tract areas. Its product portfolio consists of indwelling Foley catheters that are used for drainage and irrigation of the bladder or for the collection and measurement of patient urine; endotracheal tubes for use in airway management by oral or nasal intubation of the trachea; and central venous catheters, which is used to administer drugs and intravenous solutions, sample blood, and for blood pressure monitoring. The company markets its products through distributors in 40 countries. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Tullinge"
    },
    "C26.F": {
        "short_name": "CELLAVISION AB  SK -,15",
        "long_name": "CellaVision AB (publ)",
        "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the sub-field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, the cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was founded in 1994 and is headquartered in Lund, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "CEVI.ST": {
        "short_name": "CellaVision AB",
        "long_name": "CellaVision AB (publ)",
        "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the sub-field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, the cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was founded in 1994 and is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "CLNK-B.ST": {
        "short_name": "CELLINK AB ser. B",
        "long_name": "Cellink AB (publ)",
        "summary": "Cellink AB (publ) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide. It offers bioprinters, imaging systems, dispensing solutions, and bioinks in the field of academic and clinical medicine for labs and scientists worldwide. The company's bioprinting solutions include BIO X, a bioprinter for life-science companies, researchers, and innovators; BIO X6, a bioprinting platform for printing complex structures; INKREDIBLE and INKREDIBLE+, which are bioprinting solutions for skin, cartilage tissue, and others; Holograph X, a solution that leverages high-resolution holographic stereolithography to bioprint small structures; Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures, and others; and tool heads and print heads. It also offers biofluidics solutions, which include I-DOT, a solution for liquid-handling tasks; single-cell printer, an automated laboratory instrument; c.sight, a single-cell dispensing technology for cell line development and single-cell genomics; b.sight, a solution that enables prokaryotic cell isolation in the sub-micron range; and f.sight, a solution that dispenses unlabeled and fluorescent cells. The company offers bioinks for various applications, such as drug screening, tissue models, tissue regeneration, organoids, immunotherapy, microfluidics, scaffolds, encapsulation, wound healing, cosmetics, educational models, and others; CELLCYTE X, a live cell microscopy imaging system; and accessories, such as consumables, needles, and nozzles. Its customers also include universities, hospitals, and public and commercial laboratories. Cellink AB (publ) has a collaboration with MedImmune; and strategic partnership with Made In Space, Inc. It also offers products online. The company was founded in 2016 and is based in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "CLS-B.ST": {
        "short_name": "Clinical Laserthermia Systems A",
        "long_name": "Clinical Laserthermia Systems AB (publ)",
        "summary": "Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "CRAD-B.ST": {
        "short_name": "C-RAD AB ser. B",
        "long_name": "C-Rad AB (publ)",
        "summary": "C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, an advanced solution for particle therapy; Cyrpa laser positioning products; and Gemini, an X-ray detector optimized for electronic portal imaging device in radiation therapy. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "DIGN.ST": {
        "short_name": "Dignitana AB",
        "long_name": "Dignitana AB (publ.)",
        "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "DIZTF": {
        "short_name": "DIGNITANA AB",
        "long_name": "Dignitana AB (publ.)",
        "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "EPIS-B.ST": {
        "short_name": "Episurf Medical AB B",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, and the United Kingdom. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for treating elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, the company offers \u00c2\u00b5iFidelity system for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was founded in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "EPSFF": {
        "short_name": "EPISURF MEDICAL AB",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, and the United Kingdom. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for treating elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, the company offers \u00c2\u00b5iFidelity system for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was founded in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "GPXMED.ST": {
        "short_name": "GPX Medical AB",
        "long_name": "GPX Medical AB (publ)",
        "summary": "GPX Medical AB operates as a medical technology company. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provide intensive care and healthier lives for preterm born infants. The company was founded in 2016 and headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "HANDI.ST": {
        "short_name": "Handicare Group AB",
        "long_name": "Handicare Group AB (publ)",
        "summary": "Handicare Group AB (publ) provides mobility products and solutions for physically challenged or elderly people in North America, Asia, and Europe. The company manufactures and sells curved and straight stair lifts, transfer products, lifting and repositioning aids, vehicle accessibility products, and medical equipment and consumables, as well as offers maintenance and installation services. It serves hospitals, long-term care facilities, home care, and private individuals through dealers, and government and local authorities. The company was founded in 1986 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "HEMC.ST": {
        "short_name": "Hemcheck Sweden AB",
        "long_name": "Hemcheck Sweden AB (publ)",
        "summary": "Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Karlstad"
    },
    "ICO.ST": {
        "short_name": "Iconovo AB",
        "long_name": "Iconovo AB (publ)",
        "summary": "Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a reservoir-based dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a unit dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company was founded in 2013 and is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Lund"
    },
    "IRRAS.ST": {
        "short_name": "IRRAS AB",
        "long_name": "IRRAS AB (publ)",
        "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to improve the lives of critically ill patients worldwide. The company designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. It offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. The company also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include SynergyDuo Ventricular Catheter (H610), and Parenchymal Catheter (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "LUR.F": {
        "short_name": "LUXBRIGHT AB",
        "long_name": "Luxbright AB (publ)",
        "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "LXB.ST": {
        "short_name": "Luxbright AB",
        "long_name": "Luxbright AB (publ)",
        "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "MN2.F": {
        "short_name": "MENTICE AB  SK -,20",
        "long_name": "Mentice AB (publ)",
        "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "MNTC.ST": {
        "short_name": "Mentice AB",
        "long_name": "Mentice AB (publ)",
        "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "OSSD.ST": {
        "short_name": "OssDsign AB",
        "long_name": "OssDsign AB (publ)",
        "summary": "OssDsign AB (publ), a medtech company, designs, manufactures, and markets implants for healing of bone defects in Sweden and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage. The company was founded in 2011 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "PAX.ST": {
        "short_name": "Paxman AB",
        "long_name": "Paxman AB (publ)",
        "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Karlshamn"
    },
    "PHLOG-B.ST": {
        "short_name": "Pharmacolog i Uppsala AB ser. B",
        "long_name": "Pharmacolog i Uppsala AB (publ)",
        "summary": "Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, an integrated system to monitor and safeguard discarded narcotics from surgical procedures; and PerpLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of end result. The company was founded in 2007 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "PXMBF": {
        "short_name": "PAXMAN AB",
        "long_name": "Paxman AB (publ)",
        "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "city": "Karlshamn"
    },
    "QLIFE.ST": {
        "short_name": "QLife Holding AB",
        "long_name": "Qlife Holding AB (publ)",
        "summary": "Qlife Holding AB (publ), a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. It offers Egoo Home System, an integrated platform consisting of a small home device and disposable capsules each of that test for a specific biomarker, as well as a digital infrastructure that shares data with patient journal or hospital platform. The company has a research agreement with Nordsj\u00c3\u00a6llands Hospital to continue the validation of the Egoo Sars-CoV-2 virus test. The company was founded in 2019 and is based in Helsingborg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Helsingborg"
    },
    "SCIB.ST": {
        "short_name": "Scibase Holding AB",
        "long_name": "SciBase Holding AB (publ)",
        "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Stockholm"
    },
    "SDOS.ST": {
        "short_name": "ScandiDos AB",
        "long_name": "ScandiDos AB (publ)",
        "summary": "ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation; and Delta4 Trolley, an ergonomic solution. The company is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "SECT-B.ST": {
        "short_name": "SECTRA AB ser B",
        "long_name": "Sectra AB (publ)",
        "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Link\u00c3\u00b6ping"
    },
    "SEZI.ST": {
        "short_name": "Senzime AB",
        "long_name": "Senzime AB (publ)",
        "summary": "Senzime AB (publ) develps and markets patient monitoring systems to monitor patients under anesthesia in Europe and the United States. The company offers TetraGraph, a TOF-monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; CliniSenz Analyzer, which detects early signs of complications; and Onzurf Probe for sampling from the surface of an organ. Senzime AB (publ) was founded in 1999 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Uppsala"
    },
    "STIL.ST": {
        "short_name": "Stille AB",
        "long_name": "Stille AB",
        "summary": "Stille AB manufactures and sells surgical instruments in Sweden and internationally. The company offers artery and ligature clamps; artery forceps; bone cutters and rongeurs; clamps; curettes, raspatories, elevators, etc.; forceps; micro instruments; needle holder, wire twistings, and holding forceps; osteotomes, chisels, etc.; reactors and skin hooks; scissors; and other products. It also provides operating tables for ERCP / abdominal fluoroscopy, neuro / spine, pain management, urology, and vascular surgeries. The company was founded in 1841 and is headquartered in Torsh\u00c3\u00a4lla, Sweden. Stille AB is a subsidiary of Linc AB.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Torsh\u00c3\u00a4lla"
    },
    "VITR.ST": {
        "short_name": "Vitrolife AB",
        "long_name": "Vitrolife AB (publ)",
        "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors; and pH online. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "VTFN.F": {
        "short_name": "VITROLIFE AB  SK 0,2",
        "long_name": "Vitrolife AB (publ)",
        "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors; and pH online. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "XVIPF": {
        "short_name": "XVIVO PERFUSION AB",
        "long_name": "Xvivo Perfusion AB (publ)",
        "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "city": "Gothenburg"
    },
    "XVIVO.ST": {
        "short_name": "Xvivo Perfusion AB",
        "long_name": "Xvivo Perfusion AB (publ)",
        "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "city": "Gothenburg"
    }
}